• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CDM
Click for more information
0.72% 69.0¢

CADENCE CAPITAL LIMITED - Announcements

Market Cap $215.9M  ! watchlist Created with Sketch. Add to my watchlist

Cadence Capital Limited is an Australia-based investment company. The Company is engaged... Cadence Capital Limited is an Australia-based investment company. The Company is engaged in investing primarily in securities listed both in Australia and internationally. The Company may take short positions and may also deal in derivatives. The Company has only one segment. It operates predominately in Australia and in one industry being the securities industry. It invests in various sectors, including basic materials, energy, communications, financial, insurance, industrial, utilities, technology, and consumer, non-cyclical. The Company is managed by Cadence Asset Management Pty Limited.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CDM Change of Director's Interest Notice28/04/17
CDM Change of Director's Interest Notice28/04/17
CDM Appendix 3B28/04/17
CDM Investment Update and NTA March 201718/04/17
CDM Investment Update and NTA February 201714/03/17
CDM Media Release - Record Half Year Profit15/02/17
CDM Dividend/Distribution - CDM15/02/17
CDM Appendix 4D Half Year Report to 31 December 2016PRICE SENSITIVE15/02/17
CDM Investment Update and NTA January 201713/02/17
CDM Change in substantial holding18/01/17
CDM Investment Update and NTA December 201613/01/17
CDM Investment Update and NTA November 201613/12/16
CDM Management Agreement02/12/16
CDM Results of AGM25/11/16
CDM AGM and Investor Briefing PresentationPRICE SENSITIVE25/11/16
CDM AGM and Investor Briefing Update15/11/16
CDM Investment Update and NTA October 201609/11/16
CDM Change of Director's Interest Notice-CDM.AX 27/10/16
CDM Change of Director's Interest Notice-CDM.AX 27/10/16
CDM Appendix 3B-CDM.AX 27/10/16
CDM Change in substantial holding from CDM,CDM-MLB.AX 25/10/16
CDM Annual General Meeting Proxy Form-CDM.AX 25/10/16
CDM Notice of AGM and Investor Briefing-CDM.AX 25/10/16
CDM Investment Update and NTA September 2016-CDM.AX 14/10/16
CDM Appendix 4G-CDM.AX 30/09/16
CDM Annual Report June 2016-CDM.AX 30/09/16
CDM Investment Update and NTA August 2016-CDM.AX 09/09/16
CDM Dividend/Distribution - CDM-CDM.AX 31/08/16
CDM Media Release - Full Year Results-CDM.AX 31/08/16
CDM Appendix 4E/ Preliminary Final Report June 2016-CDM.AX PRICE SENSITIVE31/08/16
CDM Investment Update and NTA July 2016 - CORRECTED-CDM.AX 16/08/16
CDM Investment Update and NTA July 2016-CDM.AX 15/08/16
CDM Investment Update and NTA June 2016-CDM.AX 15/07/16
CDM Change in substantial holding from CDM,CDM-MLB.AX 04/07/16
CDM Change in substantial holding from CDM,CDM-MLB.AX 04/07/16
CDM Investment Update and NTA May 2016-CDM.AX 09/06/16
CDM Change of Director's Interest Notice-CDM.AX 17/05/16
CDM Change of Director's Interest Notice-CDM.AX 17/05/16
CDM Investment Update and NTA April 2016-CDM.AX 16/05/16
CDM Appendix 3B-CDM.AX 12/05/16
CDM Investment Update and NTA March 2016-CDM.AX 15/04/16
CDM Change in substantial holding from CDM24/03/16
CDM Investment Update and NTA February 201615/03/16
CDM Media Release - Half Year Results16/02/16
CDM Dividend/Distribution - CDM16/02/16
CDM Appendix 4D Half Year Report to 31 Dec 2015PRICE SENSITIVE16/02/16
CDM Investment Update and NTA January 201615/02/16
CDM Becoming a substantial holder from CDM27/01/16
CDM Amended Header Investment Update and NTA December 201514/01/16
CDM Investment Update and NTA November 201514/01/16
CDM Investment Update and NTA November 201509/12/15
CDM Appointment of Auditor27/11/15
CDM Results of AGM23/11/15
CDM AGM and Investor Briefing Presentation23/11/15
CDM AGM and Investor Briefing Update18/11/15
CDM Investment Update and NTA October 201512/11/15
CDM Change of Director's Interest Notice30/10/15
CDM Change of Director's Interest Notice30/10/15
CDM Appendix 3B29/10/15
CDM Annual General Meeting Proxy Form26/10/15
CDM Notice of AGM and Investor Briefing with Covering Letter26/10/15
CDM Quarterly webcast and 10-year anniversary23/10/15
CDM Cleansing Notice Placement16/10/15
CDM Investment Update and NTA September 201514/10/15
CDM Appendix 3B09/10/15
CDM Reinstatement to Official QuotationPRICE SENSITIVE02/10/15
CDM Placement02/10/15
CDM Suspension from Official QuotationPRICE SENSITIVE01/10/15
CDM Annual Report June 201530/09/15
CDM Cadence Capital Limited PlacementPRICE SENSITIVE28/09/15
CDM Trading HaltPRICE SENSITIVE28/09/15
CDM Investment Update and NTA August 201515/09/15
CDM Appendix 3B04/09/15
CDM Change of Director's Interest Notice02/09/15
CDM Appendix 3B02/09/15
CDM Appendix 3B31/08/15
CDM Change in substantial holding from CDM31/08/15
CDM Change of Director's Interest Notice28/08/15
CDM Change of Director's Interest Notice28/08/15
CDM Appendix 3B28/08/15
CDM Appendix 3B26/08/15
CDM Appendix 3B25/08/15
CDM Appendix 3B21/08/15
CDM Appendix 3B19/08/15
CDM Appendix 3B18/08/15
CDM Appendix 3B17/08/15
CDM Appendix 3B14/08/15
CDM Change in substantial holding13/08/15
CDM Change of Director's Interest Notice13/08/15
CDM Appendix 3B12/08/15
CDM Appendix 3B11/08/15
CDM Appendix 3B10/08/15
CDM Appendix 3B07/08/15
CDM Dividend/Distribution - CDMPRICE SENSITIVE07/08/15
CDM Appendix 3B06/08/15
CDM Broker Presentation August 201506/08/15
CDM Corrected Media Release - Full Year Results06/08/15
CDM Media Release - Full Year Results05/08/15
CDM Appendix 4E/ Preliminary Final Report June 2015PRICE SENSITIVE05/08/15
CDM Appendix 3B04/08/15
CDM Change of Director's Interest Notice
28/04/17
CDM Change of Director's Interest Notice
28/04/17
CDM Appendix 3B
28/04/17
CDM Investment Update and NTA March 2017
18/04/17
CDM Investment Update and NTA February 2017
14/03/17
CDM Media Release - Record Half Year Profit
15/02/17
CDM Dividend/Distribution - CDM
15/02/17
CDM Appendix 4D Half Year Report to 31 December 2016
15/02/17PRICE SENSITIVE
CDM Investment Update and NTA January 2017
13/02/17
CDM Change in substantial holding
18/01/17
CDM Investment Update and NTA December 2016
13/01/17
CDM Investment Update and NTA November 2016
13/12/16
CDM Management Agreement
02/12/16
CDM Results of AGM
25/11/16
CDM AGM and Investor Briefing Presentation
25/11/16PRICE SENSITIVE
CDM AGM and Investor Briefing Update
15/11/16
CDM Investment Update and NTA October 2016
09/11/16
CDM Change of Director's Interest Notice-CDM.AX
27/10/16
CDM Change of Director's Interest Notice-CDM.AX
27/10/16
CDM Appendix 3B-CDM.AX
27/10/16
CDM Change in substantial holding from CDM,CDM-MLB.AX
25/10/16
CDM Annual General Meeting Proxy Form-CDM.AX
25/10/16
CDM Notice of AGM and Investor Briefing-CDM.AX
25/10/16
CDM Investment Update and NTA September 2016-CDM.AX
14/10/16
CDM Appendix 4G-CDM.AX
30/09/16
CDM Annual Report June 2016-CDM.AX
30/09/16
CDM Investment Update and NTA August 2016-CDM.AX
09/09/16
CDM Dividend/Distribution - CDM-CDM.AX
31/08/16
CDM Media Release - Full Year Results-CDM.AX
31/08/16
CDM Appendix 4E/ Preliminary Final Report June 2016-CDM.AX
31/08/16PRICE SENSITIVE
CDM Investment Update and NTA July 2016 - CORRECTED-CDM.AX
16/08/16
CDM Investment Update and NTA July 2016-CDM.AX
15/08/16
CDM Investment Update and NTA June 2016-CDM.AX
15/07/16
CDM Change in substantial holding from CDM,CDM-MLB.AX
04/07/16
CDM Change in substantial holding from CDM,CDM-MLB.AX
04/07/16
CDM Investment Update and NTA May 2016-CDM.AX
09/06/16
CDM Change of Director's Interest Notice-CDM.AX
17/05/16
CDM Change of Director's Interest Notice-CDM.AX
17/05/16
CDM Investment Update and NTA April 2016-CDM.AX
16/05/16
CDM Appendix 3B-CDM.AX
12/05/16
CDM Investment Update and NTA March 2016-CDM.AX
15/04/16
CDM Change in substantial holding from CDM
24/03/16
CDM Investment Update and NTA February 2016
15/03/16
CDM Media Release - Half Year Results
16/02/16
CDM Dividend/Distribution - CDM
16/02/16
CDM Appendix 4D Half Year Report to 31 Dec 2015
16/02/16PRICE SENSITIVE
CDM Investment Update and NTA January 2016
15/02/16
CDM Becoming a substantial holder from CDM
27/01/16
CDM Amended Header Investment Update and NTA December 2015
14/01/16
CDM Investment Update and NTA November 2015
14/01/16
CDM Investment Update and NTA November 2015
09/12/15
CDM Appointment of Auditor
27/11/15
CDM Results of AGM
23/11/15
CDM AGM and Investor Briefing Presentation
23/11/15
CDM AGM and Investor Briefing Update
18/11/15
CDM Investment Update and NTA October 2015
12/11/15
CDM Change of Director's Interest Notice
30/10/15
CDM Change of Director's Interest Notice
30/10/15
CDM Appendix 3B
29/10/15
CDM Annual General Meeting Proxy Form
26/10/15
CDM Notice of AGM and Investor Briefing with Covering Letter
26/10/15
CDM Quarterly webcast and 10-year anniversary
23/10/15
CDM Cleansing Notice Placement
16/10/15
CDM Investment Update and NTA September 2015
14/10/15
CDM Appendix 3B
09/10/15
CDM Reinstatement to Official Quotation
02/10/15PRICE SENSITIVE
CDM Placement
02/10/15
CDM Suspension from Official Quotation
01/10/15PRICE SENSITIVE
CDM Annual Report June 2015
30/09/15
CDM Cadence Capital Limited Placement
28/09/15PRICE SENSITIVE
CDM Trading Halt
28/09/15PRICE SENSITIVE
CDM Investment Update and NTA August 2015
15/09/15
CDM Appendix 3B
04/09/15
CDM Change of Director's Interest Notice
02/09/15
CDM Appendix 3B
02/09/15
CDM Appendix 3B
31/08/15
CDM Change in substantial holding from CDM
31/08/15
CDM Change of Director's Interest Notice
28/08/15
CDM Change of Director's Interest Notice
28/08/15
CDM Appendix 3B
28/08/15
CDM Appendix 3B
26/08/15
CDM Appendix 3B
25/08/15
CDM Appendix 3B
21/08/15
CDM Appendix 3B
19/08/15
CDM Appendix 3B
18/08/15
CDM Appendix 3B
17/08/15
CDM Appendix 3B
14/08/15
CDM Change in substantial holding
13/08/15
CDM Change of Director's Interest Notice
13/08/15
CDM Appendix 3B
12/08/15
CDM Appendix 3B
11/08/15
CDM Appendix 3B
10/08/15
CDM Appendix 3B
07/08/15
CDM Dividend/Distribution - CDM
07/08/15PRICE SENSITIVE
CDM Appendix 3B
06/08/15
CDM Broker Presentation August 2015
06/08/15
CDM Corrected Media Release - Full Year Results
06/08/15
CDM Media Release - Full Year Results
05/08/15
CDM Appendix 4E/ Preliminary Final Report June 2015
05/08/15PRICE SENSITIVE
CDM Appendix 3B
04/08/15
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
69.0¢ 		Change
-0.005(0.72%) 		Mkt cap ! $215.9M
Open High Low Value Volume
69.0¢ 69.5¢ 68.5¢ $102.6K 149.2K

Buyers (Bids)

No. Vol. Price($)
1 15625 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.5¢ 9965 1
View Market Depth
Last trade - 15.56pm 22/11/2024 (20 minute delay) ?
Last
69.0¢ 		  Change
-0.005 ( 0.73 %)
Open High Low Volume
69.0¢ 69.0¢ 68.5¢ 57562
Last updated 15.56pm 22/11/2024 ?
CDM (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.